ASCO GU Report 2013 – Small renal cancers may not need surgery
by Eoghan McNeill – Orlando, Florida – When clinicians observe incidental kidney masses, about 78% of the time they are surgically removed – but a new study suggests… read more.
by Eoghan McNeill – Orlando, Florida – When clinicians observe incidental kidney masses, about 78% of the time they are surgically removed – but a new study suggests… read more.
by Christine Clark FRPharmS – In association with A.Menarini Pharmaceuticals Ireland Ltd. and Daiichi Sankyo Pharmaceuticals Ireland Ltd.
Home blood pressure monitoring may help patients with hypertension and stroke but did not improve blood pressure control for patients who had normal blood pressure at the start… read more.
Adults 18-24 years old with high blood pressure were 28 percent less likely to be diagnosed during doctor visits than those 60 and older, according to findings presented… read more.
New research at Saint Louis University shows physicians do not talk to patients about the psychosocial impact and long-term risks of implanting cardioverter defibrillators (ICDs) to treat irregular… read more.
For nearly a decade, breast cancer researchers studying the hormone therapy tamoxifen have been divided as to whether genetic differences in liver enzymes affect the drug’s effectiveness and… read more.
In association with A.Menarini Pharmaceuticals Ireland Ltd – Beta-blockers are one of the most valuable classes of drugs in the therapeutic armamentarium. They have an established place in… read more.
Taken from The Lancet – by Bruce Sylvester – Patients with cough treated with amoxicillin do not recover significantly more quickly or have significantly fewer symptoms than other… read more.
World Health Matters – China – by Gary Finnegan – A study of nearly 6,000 people in five provinces in China has shown that people exposed to passive… read more.
EMA Highlights by Gary Finnegan – Pharmaceutical companies will have to pay more to have their new medicines evaluated, if the European Medicines Agency is to balance its… read more.
EMA Highlights by Gary Finnegan – Several new medicines have been approved by the EMA’s influential Committee for Medicinal Products for Human Use (CHMP), including the first non-surgical… read more.
EMA Highlights by Eoghan McNeill – The EMA has published revised guidelines on the evaluation of anti-cancer medicines to take account of advances in research and new therapeutic… read more.
Advertisment